S
Stephen Barnett
Researcher at Royal Melbourne Hospital
Publications - 54
Citations - 844
Stephen Barnett is an academic researcher from Royal Melbourne Hospital. The author has contributed to research in topics: Lung cancer & Survival rate. The author has an hindex of 11, co-authored 53 publications receiving 693 citations. Previous affiliations of Stephen Barnett include Austin Hospital & University of Melbourne.
Papers
More filters
Journal ArticleDOI
Correlation of Mutation Status and Survival with Predominant Histologic Subtype According to the New IASLC/ATS/ERS Lung Adenocarcinoma Classification in Stage III (N2) Patients
Prudence A. Russell,Stephen Barnett,Marzena Walkiewicz,Zoe Wainer,Matthew Conron,Gavin M. Wright,Julian Gooi,Simon Knight,Rochelle Wynne,Danny Liew,Thomas John +10 more
TL;DR: The predominant subtype in the primary tumor was associated with overall survival in resected stage III (N2) lung adenocarcinoma and was independent of mutation status.
Journal ArticleDOI
General Practice training and virtual communities of practice - A review of the literature
TL;DR: This literature review will critically examine the current evidence relevant to virtual communities of practice in General Practice training, identify evidence-based principles that might guide their construction and suggest further avenues for research.
Journal ArticleDOI
The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma.
Bibhusal Thapa,Adriana Salcedo,Xihui Lin,Marzena Walkiewicz,Carmel Murone,Malaka Ameratunga,K. Asadi,Siddhartha Deb,Stephen Barnett,Simon R. Knight,Paul Mitchell,D. Neil Watkins,Paul C. Boutros,Paul C. Boutros,Thomas John +14 more
TL;DR: PD‐L1 expression was associated with nonepithelioid MPM, poor clinical outcome, and increased immunological infiltrates and copy number aberrations.
Journal ArticleDOI
Implementing a virtual community of practice for family physician training: a mixed-methods case study.
TL;DR: The usefulness of a 7-step framework for implementation of an online community for general practitioner (GP) training and the usefulness of the resulting VCoP in facilitating knowledge sharing and reducing professional isolation are evaluated.
Journal ArticleDOI
The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer.
Thomas John,Maud H.W. Starmans,Maud H.W. Starmans,Yao-Tseng Chen,Prudence A. Russell,Stephen Barnett,Shane White,Paul Mitchell,Marzena Walkiewicz,Arun Azad,Philippe Lambin,Ming-Sound Tsao,Siddhartha Deb,Nasser K. Altorki,Gavin M. Wright,Simon R. Knight,Paul C. Boutros,Paul C. Boutros,Jonathan Cebon +18 more
TL;DR: NY-ESO-1 was predictive of increased response to neoadjuvant chemotherapy and benefit from adjuvant chemotherapy, and independent gene expression data from the JBR.10 dataset support these findings but were underpowered to demonstrate significant differences.